NDC 51662-1589

LIDOCAINE HCl AND EPI

Lidocaine Hcl And Epi

LIDOCAINE HCl AND EPI is a Infiltration; Perineural Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Epinephrine Bitartrate; Lidocaine Hydrochloride Anhydrous.

Product ID51662-1589_e52110a0-d181-53a1-e053-2995a90ae9b1
NDC51662-1589
Product TypeHuman Prescription Drug
Proprietary NameLIDOCAINE HCl AND EPI
Generic NameLidocaine Hcl And Epi
Dosage FormInjection, Solution
Route of AdministrationINFILTRATION; PERINEURAL
Marketing Start Date2022-07-31
Marketing CategoryNDA /
Application NumberNDA006488
Labeler NameHF Acquisition Co LLC, DBA HealthFirst
Substance NameEPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS
Active Ingredient Strength0 mg/mL; mg/mL
Pharm ClassesAdrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 51662-1589-3

25 POUCH in 1 CASE (51662-1589-3) > 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1589-2) > 50 mL in 1 VIAL, MULTI-DOSE
Marketing Start Date2022-07-31
NDC Exclude FlagN
Sample Package?N

Drug Details


© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.